Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
| 2021-06-04 Purchase |
2021-12-09 4:05 pm |
Bolt Biotherapeutics Inc. | BOLT | Quinn William P. Chief Financial Officer |
6,256 | $7.044 | $44,067 | 20,154 (Direct) |
View |
| 2021-02-09 Purchase |
2021-02-11 4:39 pm |
Bolt Biotherapeutics Inc. | BOLT | Novo Holdings A/S 10% Owner |
400,000 | $20 | $8,000,000 | 4,503,991 (Direct) |
View |
| 2021-02-09 Purchase |
2021-02-09 6:04 pm |
Bolt Biotherapeutics Inc. | BOLT | Sofinnova Venture Partners X L.P. Sofinnova Management X L.L.C. Katabi Maha POWELL MICHAEL 10% Owner |
450,000 | $20 | $9,000,000 | 2,754,437 (Direct) |
View |
| 2021-02-09 Purchase |
2021-02-09 3:37 pm |
Bolt Biotherapeutics Inc. | BOLT | Vivo Capital VIII LLC Vivo Capital Fund VIII L.P. Vivo Capital Surplus Fund VIII L.P. Vivo Panda Fund L.P. Vivo Panda LLC Vivo Opportunity Fund L.P. Vivo Opportunity LLC 10% Owner |
350,000 | $20 | $7,000,000 | 150,000 (Indirect) |
View |
| 2021-02-09 Sale |
2021-02-09 3:37 pm |
Bolt Biotherapeutics Inc. | BOLT | Vivo Capital VIII LLC Vivo Capital Fund VIII L.P. Vivo Capital Surplus Fund VIII L.P. Vivo Panda Fund L.P. Vivo Panda LLC Vivo Opportunity Fund L.P. Vivo Opportunity LLC 10% Owner |
226 | $20 | $4,520 | 150,000 (Indirect) |
View |
| 2021-02-09 Purchase |
2021-02-09 3:35 pm |
Bolt Biotherapeutics Inc. | BOLT | LAPORTE KATHLEEN Director |
1,200 | $20 | $24,000 | 1,200 (Direct) |
View |
| 2021-02-09 Sale |
2021-02-09 3:33 pm |
Bolt Biotherapeutics Inc. | BOLT | SHAH MAHENDRA Director |
62 | $20 | $1,240 | 1,448,286 (Indirect) |
View |
| 2021-02-09 Purchase |
2021-02-09 3:29 pm |
Bolt Biotherapeutics Inc. | BOLT | HEALY JAMES Director |
450,000 | $20 | $9,000,000 | 2,754,437 (Indirect) |
View |
| 2021-02-09 Purchase |
2021-02-09 3:27 pm |
Bolt Biotherapeutics Inc. | BOLT | Khanna Ashish Siri Ram Director |
2,200 | $20 | $44,000 | 2,200 (Indirect Direct) |
View |
| 2021-02-09 Purchase |
2021-02-09 3:25 pm |
Bolt Biotherapeutics Inc. | BOLT | ENGLEMAN EDGAR Director 10% Owner |
200,000 | $20 | $4,000,000 | 1,496,070 (Indirect) |
View |
| 2021-02-09 Sale |
2021-02-09 3:25 pm |
Bolt Biotherapeutics Inc. | BOLT | ENGLEMAN EDGAR Director 10% Owner |
164 | $20 | $3,280 | 1,496,070 (Indirect) |
View |
| 2021-02-09 Purchase |
2021-02-09 3:23 pm |
Bolt Biotherapeutics Inc. | BOLT | Quinn William P. Chief Financial Officer |
1,200 | $20 | $24,000 | 13,898 (Direct) |
View |
| 2021-02-09 Purchase |
2021-02-09 3:20 pm |
Bolt Biotherapeutics Inc. | BOLT | Schatzman Randall C Chief Executive Officer |
1,500 | $20 | $30,000 | 1,500 (Direct) |
View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
Ownership |
2021-12-16 4:15 pm |
N/A N/A |
Bolt Biotherapeutics Inc. | BOLT | ONETTO NICOLE Director |
0 | $0 | 0 (Direct) |
View |
| 2021-11-17 Option Award |
2021-11-19 5:35 pm |
N/A 2031-11-16 |
Bolt Biotherapeutics Inc. | BOLT | Lee Frank D. Director |
27,860 | $0 | 27,860 (Direct) |
View |
Ownership |
2021-11-19 5:31 pm |
N/A N/A |
Bolt Biotherapeutics Inc. | BOLT | Lee Frank D. Director |
0 | $0 | 0 (Direct) |
View |
| 2021-11-17 Option Award |
2021-11-19 5:28 pm |
N/A 2031-11-16 |
Bolt Biotherapeutics Inc. | BOLT | O'CALLAGHAN BRIAN Director |
27,860 | $0 | 27,860 (Direct) |
View |
Ownership |
2021-11-19 5:24 pm |
N/A N/A |
Bolt Biotherapeutics Inc. | BOLT | O'CALLAGHAN BRIAN Director |
0 | $0 | 0 (Direct) |
View |
| 2021-02-09 Conversion |
2021-02-11 4:39 pm |
N/A N/A |
Bolt Biotherapeutics Inc. | BOLT | Novo Holdings A/S 10% Owner |
8,054,176 | $0 | 4,503,991 (Direct) |
View |
| 2021-02-09 Conversion |
2021-02-09 6:04 pm |
N/A N/A |
Bolt Biotherapeutics Inc. | BOLT | Sofinnova Venture Partners X L.P. Sofinnova Management X L.L.C. Katabi Maha POWELL MICHAEL 10% Owner |
2,304,437 | $0 | 2,754,437 (Direct) |
View |
| 2021-02-09 Exercise |
2021-02-09 3:37 pm |
N/A N/A |
Bolt Biotherapeutics Inc. | BOLT | Vivo Capital VIII LLC Vivo Capital Fund VIII L.P. Vivo Capital Surplus Fund VIII L.P. Vivo Panda Fund L.P. Vivo Panda LLC Vivo Opportunity Fund L.P. Vivo Opportunity LLC 10% Owner |
64,319 | $0.07 | 150,000 (Indirect) |
View |
| 2021-02-09 Conversion |
2021-02-09 3:37 pm |
N/A N/A |
Bolt Biotherapeutics Inc. | BOLT | Vivo Capital VIII LLC Vivo Capital Fund VIII L.P. Vivo Capital Surplus Fund VIII L.P. Vivo Panda Fund L.P. Vivo Panda LLC Vivo Opportunity Fund L.P. Vivo Opportunity LLC 10% Owner |
3,414,343 | $0 | 150,000 (Indirect) |
View |
| 2021-02-09 Exercise |
2021-02-09 3:37 pm |
N/A 2028-07-26 |
Bolt Biotherapeutics Inc. | BOLT | Vivo Capital VIII LLC Vivo Capital Fund VIII L.P. Vivo Capital Surplus Fund VIII L.P. Vivo Panda Fund L.P. Vivo Panda LLC Vivo Opportunity Fund L.P. Vivo Opportunity LLC 10% Owner |
64,319 | $0 | 150,000 (Indirect) |
View |
| 2021-02-09 Exercise |
2021-02-09 3:33 pm |
N/A N/A |
Bolt Biotherapeutics Inc. | BOLT | SHAH MAHENDRA Director |
17,711 | $0.07 | 1,448,286 (Indirect) |
View |
| 2021-02-09 Conversion |
2021-02-09 3:33 pm |
N/A N/A |
Bolt Biotherapeutics Inc. | BOLT | SHAH MAHENDRA Director |
1,416,352 | $0 | 1,448,286 (Indirect) |
View |
| 2021-02-09 Exercise |
2021-02-09 3:33 pm |
N/A 2028-07-26 |
Bolt Biotherapeutics Inc. | BOLT | SHAH MAHENDRA Director |
17,711 | $0 | 1,448,286 (Indirect) |
View |
| 2021-02-09 Conversion |
2021-02-09 3:29 pm |
N/A N/A |
Bolt Biotherapeutics Inc. | BOLT | HEALY JAMES Director |
2,304,437 | $0 | 2,754,437 (Indirect) |
View |
| 2021-02-09 Exercise |
2021-02-09 3:25 pm |
N/A N/A |
Bolt Biotherapeutics Inc. | BOLT | ENGLEMAN EDGAR Director 10% Owner |
46,608 | $0.07 | 1,496,070 (Indirect) |
View |
| 2021-02-09 Conversion |
2021-02-09 3:25 pm |
N/A N/A |
Bolt Biotherapeutics Inc. | BOLT | ENGLEMAN EDGAR Director 10% Owner |
1,997,991 | $0 | 1,496,070 (Indirect) |
View |
| 2021-02-09 Exercise |
2021-02-09 3:25 pm |
N/A 2028-07-26 |
Bolt Biotherapeutics Inc. | BOLT | ENGLEMAN EDGAR Director 10% Owner |
46,608 | $0 | 1,496,070 (Indirect) |
View |
| 2021-02-04 Option Award |
2021-02-08 5:09 pm |
N/A 2031-02-03 |
Bolt Biotherapeutics Inc. | BOLT | Yonehiro Grant Chief Business Officer |
100,000 | $0 | 100,000 (Direct) |
View |
| 2021-02-04 Option Award |
2021-02-08 5:06 pm |
N/A 2031-02-03 |
Bolt Biotherapeutics Inc. | BOLT | Perez Edith A. Chief Medical Officer |
100,000 | $0 | 100,000 (Direct) |
View |
| 2021-02-04 Option Award |
2021-02-08 5:04 pm |
N/A 2031-02-03 |
Bolt Biotherapeutics Inc. | BOLT | Dornan David Chief Scientific Officer |
110,000 | $0 | 110,000 (Direct) |
View |
| 2021-02-04 Option Award |
2021-02-08 5:02 pm |
N/A 2031-02-03 |
Bolt Biotherapeutics Inc. | BOLT | Quinn William P. Chief Financial Officer |
100,000 | $0 | 100,000 (Direct) |
View |
| 2021-02-04 Option Award |
2021-02-08 4:59 pm |
N/A 2031-02-03 |
Bolt Biotherapeutics Inc. | BOLT | Schatzman Randall C Chief Executive Officer |
340,000 | $0 | 340,000 (Direct) |
View |
Ownership |
2021-02-04 8:59 pm |
N/A N/A |
Bolt Biotherapeutics Inc. | BOLT | Sofinnova Venture Partners X L.P. Sofinnova Management X L.L.C. Katabi Maha POWELL MICHAEL 10% Owner |
0 | $0 | 2,304,437 (Direct) |
View |
Ownership |
2021-02-04 7:37 pm |
N/A 2030-07-28 |
Bolt Biotherapeutics Inc. | BOLT | Perez Edith A. Chief Medical Officer |
0 | $0 | 282,142 (Direct) |
View |
Ownership |
2021-02-04 7:33 pm |
N/A N/A |
Bolt Biotherapeutics Inc. | BOLT | Vivo Capital VIII LLC Vivo Capital Fund VIII L.P. Vivo Capital Surplus Fund VIII L.P. Vivo Panda Fund L.P. Vivo Panda LLC 10% Owner |
0 | $0 | 3,521,517 (Indirect) |
View |
Ownership |
2021-02-04 6:22 pm |
N/A 2030-12-28 |
Bolt Biotherapeutics Inc. | BOLT | LAPORTE KATHLEEN Director |
0 | $0 | 27,857 (Direct) |
View |
Ownership |
2021-02-04 6:20 pm |
N/A N/A |
Bolt Biotherapeutics Inc. | BOLT | SHAH MAHENDRA Director |
0 | $0 | 1,448,348 (Indirect) |
View |
Ownership |
2021-02-04 6:17 pm |
N/A N/A |
Bolt Biotherapeutics Inc. | BOLT | HEALY JAMES Director |
0 | $0 | 2,304,437 (Indirect) |
View |
Ownership |
2021-02-04 6:07 pm |
N/A N/A |
Bolt Biotherapeutics Inc. | BOLT | MILLER RICHARD A MD Director |
0 | $0 | 26,410 (Direct) |
View |
Ownership |
2021-02-04 5:57 pm |
N/A 2030-09-10 |
Bolt Biotherapeutics Inc. | BOLT | Khanna Ashish Siri Ram Director |
0 | $0 | 10,000 (Indirect) |
View |
Ownership |
2021-02-04 5:55 pm |
N/A N/A |
Bolt Biotherapeutics Inc. | BOLT | ENGLEMAN EDGAR Director 10% Owner |
0 | $0 | 3,351,396 (Indirect) |
View |
Ownership |
2021-02-04 5:49 pm |
N/A 2027-01-17 |
Bolt Biotherapeutics Inc. | BOLT | Yonehiro Grant Chief Business Officer |
0 | $0 | 262,724 (Direct) |
View |
Ownership |
2021-02-04 5:32 pm |
N/A 2028-01-16 |
Bolt Biotherapeutics Inc. | BOLT | Dornan David Chief Scientific Officer |
0 | $0 | 231,160 (Direct) |
View |
Ownership |
2021-02-04 5:31 pm |
N/A N/A |
Bolt Biotherapeutics Inc. | BOLT | Novo Holdings A/S 10% Owner |
0 | $0 | 4,103,991 (Direct) |
View |
Ownership |
2021-02-04 5:28 pm |
N/A N/A |
Bolt Biotherapeutics Inc. | BOLT | Quinn William P. Chief Financial Officer |
0 | $0 | 243,570 (Direct) |
View |
Ownership |
2021-02-04 5:22 pm |
N/A 2029-09-06 |
Bolt Biotherapeutics Inc. | BOLT | Schatzman Randall C Chief Executive Officer |
0 | $0 | 1,069,756 (Direct) |
View |